End Stage Renal Disease (ESRD): Clinical Trials

67 trials for End Stage Renal Disease (ESRD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 14 recruiting, 8 not yet recruiting, 7 active not recruiting. 33 Not applicable, 7 Phase 1, 6 Phase 2, 5 Phase 4, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable33Completed 15, Recruiting 7, Not yet recruiting 4, Active not recruiting 2, Terminated 2, Withdrawn 2, Unknown 1
Phase 17Completed 4, Active not recruiting 2, Recruiting 1
Phase 26Completed 2, Recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 45Completed 3, Active not recruiting 1, Recruiting 1
Phase 33Completed 2, Active not recruiting 1

Follow End Stage Renal Disease (ESRD): new trials by email Literature Review of End Stage Renal Disease (ESRD) trials Research Report on End Stage Renal Disease (ESRD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multi-Site STARgraft (10401) Trial
STARgraft (10401), Gore Propaten - End Stage Renal Disease (ESRD)
Not applicableNot yet recruitingHealionics Corporation1112026-10-012026-08-13
DKK3 as a Biomarker of Peritoneal Fibrosis in Peritoneal Dialysis Patients
Modified Peritoneal Equilibration Test and DKK3 Biomarker Measurement - Peritoneal Dialysis (PD), End Stage Renal Disease (ESRD)
Not yet recruitingUniversität des Saarlandes302026-09-012026-09-08
Effectiveness of Subgingival Instrumentation on Delaying End-stage Renal Disease Among Chronic Kidney Disease Patients
Subgingival Instrumentation, Oral Hygiene Instructions - Chronic Kidney Disease, Periodontitis
Not applicableNot yet recruitingPostgraduate Institute of Dental Sciences Rohtak402026-07-012026-06-18
Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission
Relative Blood Volume Monitoring (RBVM) - End Stage Renal Disease (ESRD), Volume Overload
Enrolling by invitationMassachusetts General Hospital4002026-06-172026-10-08
Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
Remote patient monitoring-automated peritoneal (RPM-APD), Manual peritoneal dialysis (PD) cohort, Maintenance hemodialysis (HD) - End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD)
RecruitingVantive Health LLC7502026-06-172026-08-24
Dry Weight Reduction Intervention Via Extra Ultrafiltration
Ultrafiltration - Fluid Accumulation, Blood Pressure Management
Not applicableNot yet recruitingUniversity of Washington1202026-06-012026-06-09
Exploring the Modulatory Effect of the Dialyzer Membrane Choice on Hemodialysisassociated Thromboinflammation: a Prospective Randomized Cross-over Trial
Use of a polysulfone membrane, Use of an asymmetric triacetate membrane, Use of a polymethyl methacrylate membrane - Hemodialysis, End Stage Renal Disease (ESRD)
Not applicableActive not recruitingUniversitair Ziekenhuis Brussel102026-04-132026-07-06
Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)
Calciphylaxis, Calcific Uremic Arteriolopathy
RecruitingOdense University Hospital8602026-04-012026-04-06
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
Expanded Hemodialysis With Medium Cut-Off Membrane, High-Volume Online Hemodiafiltration - End Stage Renal Disease (ESRD), Chronic Kidney Disease on Hemodialysis
Not applicableNot yet recruitingInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran152026-04-012026-03-24
Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients
Plant-Focused Diet Counselling, Standard Renal Diet Counselling - End Stage Renal Disease (ESRD), End Stage Kidney Disease (ESRD)
Not applicableRecruitingNational University of Malaysia1002026-03-102026-03-16
EndoForce Post Approval Study
End Stage Renal Disease (ESRD)
RecruitingPhraxis, Inc.1502026-01-132026-01-21
Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients
Tuberculin Skin Test (TST) - Latent Tuberculosis Infection, End Stage Renal Disease (ESRD)
Not yet recruitingSohag University2002025-12-012025-10-07
Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation
Omnisol organ preservation solution - Kidney Transplant, Kidney Failure
Not applicableRecruitingVivalyx GmbH152025-11-172026-08-28
RaDIANT Health Systems Intervention
Performance Feedback Reports on Referral and Evaluation Closures, Dialysis Facility Awareness Campaign, Patient Contact via Preferred Method - End Stage Renal Disease (ESRD), Kidney Disease
Not applicableRecruitingIndiana University140002025-10-272026-05-26
Pivotal Study of the Velocity™ pAVF System
Velocity Percutaneous Arteriovenous Fistula - Chronic Kidney Disease, Hemodialysis Access
Not applicableRecruitingVenova Medical1262025-10-212026-09-02
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
APP-based management - End Stage Renal Disease (ESRD), Maintenance Hemodialysis
Not applicableRecruitingYunfeng Xia3922025-09-222025-12-18
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
LY3537031 - Renal Impairment, Healthy
Phase 1CompletedEli Lilly and Company312025-09-182026-04-24
Activated Charcoal Use in Chronic Kidney Disease Patients
Activated Charcoal, Phosphate Binders - End Stage Renal Disease (ESRD), CKD 5D, Hemodialysis
Phase 2RecruitingMansoura University402025-08-012025-08-08
TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation
Testosterone Replacement Therapy - Hypogonadism, Male, End Stage Renal Disease (ESRD)
Phase 1 / Phase 2Active not recruitingUniversity of California, Los Angeles502025-07-012025-12-17
Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Hemodialysis-associated Thromboinflammation
Hemodialysis using dialysate containing citric acid and magnesium at a concentration of 1.0 mmol/L, Hemodialysis using acetic acid dialysate with magnesium 0.5 mmol/L, Hemodialysis using citric acid dialysate with magnesium 0.75 mmol/L - Hemodialysis, Thromboinflammation
Not applicableRecruitingUniversitair Ziekenhuis Brussel152025-06-052025-11-17

Showing 20 of 67. Sign in to see all of them.

Narrower conditions

Kidney Failure, Chronic (67)  ·  Renal Insufficiency, Chronic (10)  ·  Renal Insufficiency (5)  ·  Arteriovenous Fistula (4)  ·  Diabetes Mellitus (3)  ·  Acute Kidney Injury (2)  ·  Disease (2)  ·  Edema (2)  ·  Fatigue (2)  ·  Malnutrition (2)  ·  Thromboinflammation (2)  ·  Acidosis (1)  ·  Agnosia (1)  ·  Anemia (1)  ·  Bronchiolitis Obliterans Syndrome (1)

Broader conditions

Chronic Disease (67)  ·  Disease Attributes (67)  ·  Female Urogenital Diseases (67)  ·  Female Urogenital Diseases and Pregnancy Complications (67)  ·  Male Urogenital Diseases (67)  ·  Pathologic Processes (67)  ·  Pathological Conditions, Signs and Symptoms (67)  ·  Urogenital Diseases (67)  ·  Urologic Diseases (67)  ·  Kidney Diseases (66)  ·  Renal Insufficiency (62)  ·  Renal Insufficiency, Chronic (57)  ·  Nutritional and Metabolic Diseases (9)  ·  Cardiovascular Diseases (8)  ·  Metabolic Diseases (7)

Interventions

Dialysis Solutions (2)  ·  Icodextrin (2)  ·  Mycophenolic Acid (2)  ·  Adrenal Cortex Hormones (1)  ·  Amino Acids (1)  ·  Aromatherapy (1)  ·  Autogenic Training (1)  ·  Basiliximab (1)  ·  Charcoal (1)  ·  Cohort Studies (1)  ·  Continuous Glucose Monitoring (1)  ·  Control Groups (1)  ·  Cyclosporine (1)  ·  Darbepoetin alfa (1)  ·  Data Collection (1)

Sponsors

Vantive Health LLC (5)  ·  Mansoura University (2)  ·  Poitiers University Hospital (2)  ·  Pursuit Vascular, Inc. (2)  ·  Universitair Ziekenhuis Brussel (2)  ·  Venova Medical (2)  ·  Abu Dhabi Health Services Company (1)  ·  Ain Shams University (1)  ·  Amsterdam UMC, location VUmc (1)  ·  Astellas Pharma Europe B.V. (1)  ·  Cedars-Sinai Medical Center (1)  ·  Charles Drew University of Medicine and Science (1)  ·  Chengdu Qingshan Likang Pharmaceutical Co., Ltd (1)  ·  Elaine Chow (1)  ·  Eli Lilly and Company (1)

Countries

United States (27)  ·  Belgium (5)  ·  France (5)  ·  China (4)  ·  Egypt (4)  ·  Germany (4)  ·  Netherlands (4)  ·  Colombia (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Bulgaria (2)  ·  Croatia (2)  ·  Czechia (2)  ·  Hong Kong (2)  ·  India (2)

Top investigators

Ajay Gupta, MD (1)  ·  Alexandra Scholze, Dr.med, PhD (1)  ·  Alp Sener, Dr. (1)  ·  Ari Kramer, MD (1)  ·  Aydin Guclu (1)  ·  Bryan Kestenbaum, MD, MS (1)  ·  Christoph Schmaderer, M.D. (1)  ·  Fatma A Ibrahim, MSc (1)  ·  Florine Janssens, Medical Doctor (1)  ·  Florine Janssens, Medical doctor (1)  ·  Jaime Uribarri, MD (1)  ·  Jeffrey Hymes, MD (1)

Results publications

PMID 11406727, PMID 15269196, PMID 17999333, PMID 19479191, PMID 20875382, PMID 20881943, PMID 21848863, PMID 23057616, PMID 23241359, PMID 24022265, PMID 24231662, PMID 25823425, PMID 26154643, PMID 27839894, PMID 28182117, PMID 28589039, PMID 28803082, PMID 29472415, PMID 29724177, PMID 29752413, PMID 30602367, PMID 31152476, PMID 32112136, PMID 32328307, PMID 32633157, PMID 33435475, PMID 33858390, PMID 33896052, PMID 34216395, PMID 34620664, PMID 34640474, PMID 35208961, PMID 35363884, PMID 35419530, PMID 36005278, PMID 36092515, PMID 36671523, PMID 3692386, PMID 38363466, PMID 40342620, PMID 42117602, PMID 42319856, PMID 6683227, PMID 9590195

NIH funding

R01DK079682 (1), R01DK090769 (1), R01DK136283 (1), R01DK141693 (1)